Search

Your search keyword '"Immunosuppressive Agent"' showing total 2 results
Start Over Descriptor "Immunosuppressive Agent" Language portuguese
2 results on '"Immunosuppressive Agent"'

1. Sero-prevalence of bovine Leukemia virus in cattle from Caquetá state, Colombia

Author

Pablo Andrés Motta-Delgado, Luis Gabriel Rivera-Calderón, Wilmer Herrera-Valencia, Ricardo Alberto Martínez-Tovar, Marliyanini Londoño-Sánchez, Erika Paola Rojas-Vargas, Angie Liseth Muñoz-Murcia, and María Elodia Gutiérrez-Quintero

Subjects
amazon region, deltaretrovirus, epidemiology, immunosuppressive agent, lymphocytosis, lymphoma, tropical zone, Agriculture, Agriculture (General), S1-972, Animal culture, SF1-1100
Abstract

Bovine Leukemia Virus (BLV) is the agent of enzootic bovine leukosis (EBL), this disease is a neoplasm of lymphatic tissue in bovine species. The aim of this article was determinate the prevalence of bovine leukemia virus in dual-purpose cattle from nine municipalities that produce the 98% of milk in the Caquetá state, Colombia. Blood samples were collected in 100 herds dedicates to dual purpose cattle, obtained blood serum from 1000 animals, of which 893 corresponding to cows. Indirect Elisa test for detection of antibodies anti-GP51 of BLV was performance and the positive cases were considered if the serum-to-positive ratio with percentages of M/N lower than 40%. Categorized data were analyzed by contingency tables and ANOVA at the significant level of p

Published
2019
Full Text
View/download PDF

2. A comparative study of therapeutic complications in Systemic Lupus Erythematosus and in idiopathic glomerulopathy

Author

André Luis Balbi, R. A. Barbosa, D. B. Almeida, Maria Cristina Pereira Lima, and Universidade Estadual Paulista (Unesp)

Subjects
Adult, Male, medicine.medical_specialty, corticosteroid, Nephrotic Syndrome, Cyclophosphamide, retrospective study, Lupus nephritis, Gastroenterology, Methylprednisolone, Nephropathy, Lesion, lupus erythematosus nephritis, systemic lupus erythematosus, Prednisone, Adrenal Cortex Hormones, Internal medicine, Diabetes mellitus, medicine, follow up, Humans, Lupus Erythematosus, Systemic, human, comparative study, Retrospective Studies, business.industry, General Medicine, immunosuppressive agent, medicine.disease, Lupus Nephritis, Endocrinology, female, prednisone, medicine.symptom, business, Nephrotic syndrome, Immunosuppressive Agents, medicine.drug, Follow-Up Studies
Abstract

Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-27T11:20:18Z No. of bitstreams: 0Bitstream added on 2014-05-27T14:39:40Z : No. of bitstreams: 1 2-s2.0-0035495938.pdf: 91152 bytes, checksum: 0b87bd3305281fdf38da282165c8100a (MD5) Made available in DSpace on 2014-05-27T11:20:18Z (GMT). No. of bitstreams: 0 Previous issue date: 2001-10-01 PURPOSE: To evaluate the therapeutic complications due to the use of immunosupressors in patients with nephropathy. METHODS: 76 patients who had used steroids and cyclophosphamide were retrospectively studied. The cases were divided into three groups: G1= 15 patients with Systemic Lupus Erythematosus without renal lesion; G2= 33 patients with lupus nephritis and G3= 28 patients with nephrotic syndrome owing to idiopathic glomerulopathy. RESULTS: There were no differences related to time of follow up (G1= 42.4 +/- 51, G2= 52.3 +/- 51, G3= 41.8 +/- 47.8 months), total used dosage of steroids (G1= 20, G2= 28, G3= 16 grams) and time of drug use (G1= 20, G2= 26, G3= 14.5 months). About cyclophosphamide use, there was no difference in the percentage of patients who used it (13% in G1, 51% in G2, 28% in G3), but the patients from G1 received lower total dosage than those from G2 (p

Published
2001

Catalog

Books, media, physical & digital resources
See catalog results